A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge

► Virus-like particle (VLP) of coxsackievirus A16 was successfully produced. ► VLP immunization potently elicited neutralizing antibodies in mice. ► Passive transfer of anti-VLP sera protected mice against CVA16 lethal infection.